+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium



Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium



Acta Psychiatrica Scandinavica. Supplementum 360: 50-51



Moclobemide and clomipramine were compared for efficacy, tolerance and safety in 63 mixed endogenous and nonendogenous depressed patients. Treatment was given for at least 4 weeks in a double-blind, randomized, parallel-group design. The mean Hamilton Rating Scale for Depression score decreased gradually during treatment with no differences between groups. Two patients on clomipramine and none on moclobemide were withdrawn for lack of efficacy, and poor tolerance caused 3 patients on moclobemide and 7 on clomipramine to stop treatment prematurely. Patients with endogenous depression responded better to clomipramine, whereas nonendogenous disorders did better on moclobemide. Adverse events were more frequent in the clomipramine group and more of these were severe or very severe than for moclobemide. Thus, although no significant difference in efficacy was seen, moclobemide appeared to be tolerated better than clomipramine. The numbers were small, however, and many patients received concomitant medication, and the results are therefore difficult to interpret.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040711163

Download citation: RISBibTeXText

PMID: 2248071


Related references

Moclobemide versus amitriptyline in the treatment of depression: two small double-blind multicentre studies in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 52-53, 1990

Moclobemide (Ro 11-1163) vs. clomipramine in the treatment of depression: A double-blind multicenter study in Belgium. Drug Development Research 21(4): 325-331, 1990

Moclobemide ro 11 1163 vs. clomipramine in the treatment of depression a double blind multicenter study in belgium. Drug Development Research 21(4): 325-332, 1990

Moclobemide versus clomipramine in the treatment of depression: a multicentre trial in Spain. Acta Psychiatrica Scandinavica. Supplementum 360: 48-49, 1990

Moclobemide versus clomipramine in endogenous depression. A double-blind randomised clinical trial. British Journal of Psychiatry 160: 519-524, 1992

Moclobemide versus placebo in the treatment of depression: a multicentre study in Belgium. Acta Psychiatrica Scandinavica. Supplementum 360: 42, 1990

A double-blind comparison of moclobemide and thioridazine versus moclobemide and placebo in the treatment of refractory, severe depression. Journal of Clinical Psychopharmacology 15(4 Suppl 2): 41s-45s, 1995

Multicenter double-blind randomized parallel-group clinical trial of effectiveness of the combination clomipramine plus lithium carbonate versus clomipramine plus placebo in the treatment of unipolar major depression. European Neuropsychopharmacology 10(Suppl. 3): S249, 2000

Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression. Journal of Affective Disorders 76(1-3): 191-200, 2003

Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial. Acta Psychiatrica Scandinavica 104(2): 104-109, 2001

Moclobemide versus clomipramine in depressed patients in general practice. A randomized, double-blind, parallel, multicenter study. Journal of Clinical Psychopharmacology 15(4 Suppl 2): 24s-30s, 1995

Moclobemide in depression: a randomized, multicentre trial against isocarboxazide and clomipramine emphasizing atypical depression. Acta Psychiatrica Scandinavica 84(6): 564-570, 1991

Moclobemide versus fluoxetine for double depression: A randomized double-blind study. Journal of Psychiatric Research 30(6): 453-458, 1996

Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study. Human Psychopharmacology 18(2): 113-119, 2003

A double-blind, multicentre study of paroxetine versus clomipramine in depressed elderly patients. Acta Psychiatrica Scandinavica. Supplementum 350: 132-134, 1989